Selection criteria for simultaneous resection in patients with synchronous liver metastasis
- PMID: 17043279
- DOI: 10.1001/archsurg.141.10.1006
Selection criteria for simultaneous resection in patients with synchronous liver metastasis
Abstract
Hypothesis: While simultaneous resection has been shown to be safe and effective in patients with synchronous metastasis, neoadjuvant chemotherapy followed by hepatectomy has gradually gained acceptance for both initially nonresectable metastasis and resectable metastasis. The boundary between these treatments is becoming unclear. We hypothesized that factors associated with colorectal cancer may play an important role in the prognosis of patients with synchronous metastasis and may be useful for identifying patients who can be expected to have adequate results following simultaneous resection.
Design: Outcome study.
Setting: Tertiary referral center.
Patients: From January 1980 to December 2002, 187 patients underwent curative resection for synchronous liver metastasis from colorectal cancer. One hundred forty-two patients received simultaneous resection, 18 underwent staged resection, and 27 underwent delayed hepatic resection. Twenty-one clinicopathological factors were analyzed, and long-term prognosis was assessed.
Main outcome measures: Prognostic factors and patient survival.
Results: There was no in-hospital death. In a multivariate analysis, the factors that significantly affected the prognosis of synchronous metastasis were 4 or more lymph node metastases around the primary cancer (P<.001) and multiple liver metastases (P = .003). In patients with 3 or fewer lymph node metastases around the primary cancer, the 5-year survival rates of those with 1, 2 to 3, and 4 or more liver metastases were 63%, 33%, and 40%, respectively, but these rates were 15%, 22%, and 0%, respectively, in patients with 4 or more lymph node metastases around the primary cancer.
Conclusions: The results support the application of simultaneous resection in patients with 0 to 3 colorectal lymph node metastases. However, in patients with 4 or more colorectal lymph node metastases, biological selection by neoadjuvant chemotherapy may be more suitable.
Similar articles
-
[Prognostic factors of colorectal cancer patients with synchronous liver metastasis treated with simultaneous liver and colorectal resection].Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):372-5. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18953839 Chinese.
-
[Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions].Swiss Surg. 1996;Suppl 4:4-17. Swiss Surg. 1996. PMID: 8963836 German.
-
Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis.J Am Coll Surg. 2004 Jun;198(6):884-91. doi: 10.1016/j.jamcollsurg.2004.01.017. J Am Coll Surg. 2004. PMID: 15194069
-
[Diagnosis and treatment of colorectal liver metastases - workflow].Zentralbl Chir. 2008 Jun;133(3):267-84. doi: 10.1055/s-2008-1076796. Zentralbl Chir. 2008. PMID: 18563694 Review. German.
-
[Timing of resection in patients with colorectal carcinoma and synchronous liver metastases].Zentralbl Chir. 2009 Sep;134(5):425-9. doi: 10.1055/s-0029-1224612. Epub 2009 Sep 15. Zentralbl Chir. 2009. PMID: 19757342 Review. German.
Cited by
-
The surgical treatment of patients with colorectal cancer and liver metastases in the setting of the "liver first" approach.Hepatobiliary Surg Nutr. 2014 Oct;3(5):324-9. doi: 10.3978/j.issn.2304-3881.2014.09.12. Hepatobiliary Surg Nutr. 2014. PMID: 25392845 Free PMC article. Review.
-
Simultaneous colorectal and parenchymal-sparing liver resection for advanced colorectal carcinoma with synchronous liver metastases: Between conventional and mini-invasive approaches.World J Gastroenterol. 2020 Nov 14;26(42):6529-6555. doi: 10.3748/wjg.v26.i42.6529. World J Gastroenterol. 2020. PMID: 33268945 Free PMC article. Review.
-
Impact of resection for primary colorectal cancer on outcomes in patients with synchronous colorectal liver metastases.J Gastrointest Surg. 2010 Aug;14(8):1258-64. doi: 10.1007/s11605-010-1250-7. Epub 2010 Jun 11. J Gastrointest Surg. 2010. PMID: 20544397
-
Evolving management of colorectal cancer.World J Gastroenterol. 2008 Jul 7;14(25):3956-67. doi: 10.3748/wjg.14.3956. World J Gastroenterol. 2008. PMID: 18609678 Free PMC article. Review.
-
Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.HPB (Oxford). 2013 Feb;15(2):119-30. doi: 10.1111/j.1477-2574.2012.00597.x. HPB (Oxford). 2013. PMID: 23297723 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical